Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -2 of 2 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:

Last Modified: 12/10/2007 First Published: 6/1/2000


1.		Phase I Study of Melphalan and Buthionine Sulfoximine Followed By Autologous Bone Marrow or Peripheral Blood Stem Cell Support in Children With Resistant or Recurrent High-Risk Neuroblastoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Active				Over 9 months to 30 years				Other				NANT-99-02 68, N99-02, CHLA-LA-NANT-99-02, CHLA-CCI-00.020, NCT00005835

First Published: 4/16/2008


2.		Phase I Study of Buthionine Sulfoximine in Combination With Normothermic Isolated Limb Infusion of Melphalan in Patients With Persistent or Recurrent Stage IIIB or IIIC In-Transit Malignant Melanoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Biomarker/Laboratory analysis, Treatment				Active				18 and over				NCI				DUMC-PRO00001793 Pro00001793, NCT00661336

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute